These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 16640616)

  • 1. The elimination of Trypanosoma brucei gambiense sleeping sickness in the focus of Luba, Bioko Island, Equatorial Guinea.
    Simarro PP; Franco JR; Ndongo P; Nguema E; Louis FJ; Jannin J
    Trop Med Int Health; 2006 May; 11(5):636-46. PubMed ID: 16640616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A strategy to control Trypanosomiasis due to Trypanosoma brucei gambiense in an endemic region of Zaire. Association of a serological test and early treatment of suspected cases. Preliminary results].
    De Groof D; Bruneel H; Mungoma K; Ruppol JF
    Bull Soc Pathol Exot; 1993; 86(4):260-3. PubMed ID: 8292915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of human African trypanosomiasis in the Quiçama focus, Angola.
    Ruiz JA; Simarro PP; Josenando T
    Bull World Health Organ; 2002; 80(9):738-45. PubMed ID: 12378293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Control of human African trypanosomiasis in Luba in equatorial Guinea:evaluation of three methods].
    Simarro PP; Sima FO; Mir M; Mateo MJ; Roche J
    Bull World Health Organ; 1991; 69(4):451-7. PubMed ID: 1934239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Has the focus of human African trypanosomiasis in Luba, Equatorial Guinea been eradicated?].
    Simarro PP; Franco JR; Asumu PN
    Med Trop (Mars); 2001; 61(4-5):441-4. PubMed ID: 11803839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivation of an old sleeping sickness focus in Mamfe (Cameroon): epidemiological, immunological and parasitological findings.
    Asonganyi T; Hengy C; Louis JP; Ghogomu NA
    Rev Epidemiol Sante Publique; 1991; 39(1):55-62. PubMed ID: 2031097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trypanosomiasis from Trypanosoma brucei gambiense in the center of north-west Uganda. Evaluation of 5 years of control (1987-1991)].
    Paquet C; Castilla J; Mbulamberi D; Beaulieu MF; Gastellu Etchegorry MG; Moren A
    Bull Soc Pathol Exot; 1995; 88(1):38-41. PubMed ID: 7787452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of human trypanosomiasis in the Luba focus, in Equatorial Guinea].
    Simarro PP; Mas J; Lancien J; Ona Sima F; Mateo MJ; Roche J
    Rev Sanid Hig Publica (Madr); 1990; 64(9-10):517-34. PubMed ID: 2131631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The return of sleeping sickness in an epidemic form: international action for drugs].
    Kager PA
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2527-30. PubMed ID: 12532663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African Trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in southern Sudan.
    Chappuis F; Stivanello E; Adams K; Kidane S; Pittet A; Bovier PA
    Am J Trop Med Hyg; 2004 Sep; 71(3):313-7. PubMed ID: 15381812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the reactivity of the card agglutination test for trypanosomiasis (CATT) reagent in the Fontem sleeping sickness focus, Cameroon.
    Asonganyi T; Bedifeh BA; Ade SS; Ngu JL
    Afr J Med Med Sci; 1994 Mar; 23(1):39-46. PubMed ID: 7839945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interpretation of the CATT (Card Agglutination Trypanosomiasis Test) in the screening for human trypanosomiasis due to Trypanosoma brucei gambiense].
    Penchenier L; Jannin J; Moulia-Pelat JP; Elfassi de la Baume F; Fadat G; Chanfreau B; Eozenou P
    Ann Soc Belg Med Trop; 1991 Sep; 71(3):221-8. PubMed ID: 1958107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The focus of human trypanosomiasis in Campo (Cameroon). History and endemic situation in 1998].
    Penchenier L; Grébaut P; Eboó Eyenga V; Bodo JM; Njiokou F; Binzouli JJ; Simarro P; Soula G; Herder S; Laveissière C
    Bull Soc Pathol Exot; 1999 Jul; 92(3):185-90. PubMed ID: 10472446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
    Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
    J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa.
    Truc P; Lejon V; Magnus E; Jamonneau V; Nangouma A; Verloo D; Penchenier L; Büscher P
    Bull World Health Organ; 2002; 80(11):882-6. PubMed ID: 12481210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human African trypanosomiasis.
    Brun R; Blum J; Chappuis F; Burri C
    Lancet; 2010 Jan; 375(9709):148-59. PubMed ID: 19833383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Testryp CATT (Card Agglutination Test for Trypanosomiasis): a field study on gambiense sleeping sickness in Liberia.
    Zillmann U; Albiez EJ
    Trop Med Parasitol; 1986 Dec; 37(4):390-2. PubMed ID: 3551027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, controlled trial of treatments for second-stage sleeping sickness.
    Woodrow CJ; Abel PM; Krishna S
    J Infect Dis; 2007 Aug; 196(4):650-1. PubMed ID: 17624857
    [No Abstract]   [Full Text] [Related]  

  • 19. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Control of Trypanosoma gambiense trypanosomiasis. Evaluation of a strategy based on the treatment of serologically suspected cases with a single dose of diminazene].
    Bruneel H; van den Eeckhout A; Molisho D; Burke J; Degroof D; Pépin J
    Ann Soc Belg Med Trop; 1994 Sep; 74(3):203-15. PubMed ID: 7840688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.